Worsening of health disparities across COVID-19 pandemic stages in Korea
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES With the end of the coronavirus disease 2019 (COVID-19) pandemic, the health outcomes of this disease in Korea must be examined. We aimed to investigate health outcomes and disparities linked to socioeconomic status during the COVID-19 pandemic in Korea and to identify risk factors for hospitalization and mortality. METHODS This nationwide retrospective study incorporated an analysis of individuals with and without COVID-19 in Korea between January 1, 2020 and December 31, 2022. The study period was divided into 4 stages. Prevalence, hospitalization, mortality, and case-fatality rates were calculated per 100,000 population. Multivariate logistic regression was performed to identify risk factors for COVID-19 hospitalization and mortality. RESULTS Overall, the incidence rate was 40,601 per 100,000 population, the mortality rate was 105 per 100,000 population, and the case-fatality rate was 259 per 100,000 cases. A total of 12,577,367 new cases (24.5%) were recorded in stage 3 and 8,979,635 cases (17.5%) in stage 4. Medical Aid recipients displayed the lowest 3-year cumulative incidence rate (32,737 per 100,000) but the highest hospitalization (5,663 cases per 100,000), mortality (498 per 100,000), and case-fatality (1,521 per 100,000) rates. Male sex, older age, lower economic status, non-metropolitan area of residence, high Charlson comorbidity index, and disability were associated with higher risk of hospitalization and death. Vaccination was found to reduce mortality risk. CONCLUSIONS As the pandemic progressed, surges were observed in incidence, hospitalization, and mortality, exacerbating disparities associated with economic status and disability. Nevertheless, Korea has maintained a low case-fatality rate across all economic groups.
Abstract
OBJECTIVES With the end of the coronavirus disease 2019 (COVID-19) pandemic, the health outcomes of this disease in Korea must be examined. We aimed to investigate health outcomes and disparities linked to socioeconomic status during the COVID-19 pandemic in Korea and to identify risk factors for hospitalization and mortality. METHODS This nationwide retrospective study incorporated an analysis of individuals with and without COVID-19 in Korea between January 1, 2020 and December 31, 2022. The study period was divided into 4 stages. Prevalence, hospitalization, mortality, and case-fatality rates were calculated per 100,000 population. Multivariate logistic regression was performed to identify risk factors for COVID-19 hospitalization and mortality. RESULTS Overall, the incidence rate was 40,601 per 100,000 population, the mortality rate was 105 per 100,000 population, and the case-fatality rate was 259 per 100,000 cases. A total of 12,577,367 new cases (24.5%) were recorded in stage 3 and 8,979,635 cases (17.5%) in stage 4. Medical Aid recipients displayed the lowest 3-year cumulative incidence rate (32,737 per 100,000) but the highest hospitalization (5,663 cases per 100,000), mortality (498 per 100,000), and case-fatality (1,521 per 100,000) rates. Male sex, older age, lower economic status, non-metropolitan area of residence, high Charlson comorbidity index, and disability were associated with higher risk of hospitalization and death. Vaccination was found to reduce mortality risk. CONCLUSIONS As the pandemic progressed, surges were observed in incidence, hospitalization, and mortality, exacerbating disparities associated with economic status and disability. Nevertheless, Korea has maintained a low case-fatality rate across all economic groups.
참고문헌 (31)
- "WHO coronavirus disease (COVID-19) dashboard"[URL]
- "Timeline: WHO’s COVID-19 response" (2023)[URL]
- Nikolaeva A, "Analytical observational study evaluating global pandemic preparedness and the effectiveness of early COVID-19 responses in Ethiopia, Nigeria, Singapore, South Korea, Sweden, Taiwan, UK and USA", BMJ Open, 12, pp.e053374~ (2022)[DOI]
- Sachs JD, "The Lancet Commission on lessons for the future from the COVID-19 pandemic", Lancet, 400, pp.1224~1280 (2022)[DOI]
- Na BJ, "Seventy-two hours, targeting time from first COVID-19 symptom onset to hospitalization", J Korean Med Sci, 35, pp.e192~ (2020)[DOI]
- Lee H, "Power of universal health coverage in the era of COVID-19 : a nationwide observational study", Lancet Reg Health West Pac, 7, pp.100088~ (2021)[DOI]
- COVID-19, changes in infectious disease response over last 3 years, "Ministry of Health and Welfare", Ministry of Health and Welfare, ~ (2023)
- Lee DW, "Genomic epidemiology of SARS-CoV-2 Omicron variants in the Republic of Korea", Sci Rep, 12, pp.22414~ (2022)[DOI]
- "During the quarantine process, confirmed patients with COVID-19 from overseas were identified. Respond by raising the infectious disease crisis alert to the “caution” level" (2020)[URL]
- "Central Disaster Management Headquarters Pan-government Countermeasures meeting briefing (2.23) raises infectious disease crisis alert to ‘serious’" (2020)[URL]
- "Lifting of quarantine obligations for overseas entrants from June 8" (2022)[URL]
- "Implementation of the 4th phase of new distancing in the Seoul metropolitan area (7.12~7.25)" (2021)[URL]
- "Reorganization of the guidelines for responding to social welfare facilities according to the gradual transition to daily recovery (applied from November 1)" (2021)[URL]
- Tuty Kuswardhani RA, "Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients : a systematic review and meta-analysis", Diabetes Metab Syndr, 14, pp.2103~2109 (2020)[DOI]
- "R&D blueprint and COVID-19"[URL]
- Moore S, "Vaccination and non-pharmaceutical interventions for COVID-19 : a mathematical modelling study", Lancet Infect Dis, 21, pp.793~802 (2021)[DOI]
- Ryu S, "Association between the relaxation of public health and social measures and transmission of the SARS-CoV-2 Omicron variant in South Korea", JAMA Netw Open, 5, pp.e2225665~ (2022)[DOI]
- Kumar S, "Racial health disparity and COVID-19", J Neuroimmune Pharmacol, 16, pp.729~742 (2021)[DOI]
- Khanijahani A, "A systematic review of racial", ethnic and socioeconomic disparities in COVID-19, 2021, pp.20, 248~
- El-Khatib Z, "The association between out-of-pocket expenditure and COVID-19 mortality globally", J Epidemiol Glob Health, 10, pp.192~193 (2020)[DOI]
- McCain JL, "Assessing the impact of insurance type on COVID-19 mortality in black and white patients in the largest healthcare system in the state of georgia", J Natl Med Assoc, 114, pp.218~226 (2022)[DOI]
- "Coronavirus (COVID-19) deaths"[URL]
- Yi S, "Impact of national Covid-19 vaccination campaign, South Korea", Vaccine, 40, pp.3670~3675 (2022)[DOI]
- Khanijahani A, "A systematic review of racial", ethnic and socioeconomic disparities in COVID-19, 2021, pp.20, 248~
- Zhang JJ, "Risk and protective factors for COVID-19 morbidity, severity, and mortality", Clin Rev Allergy Immunol, 64, pp.90~107 (2023)[DOI]
- Argun Barış S, "Charlson comorbidity index in predicting poor clinical outcomes and mortality in patients with COVID-19", Turk Thorac J, 23, pp.145~153 (2022)[DOI]
- Bergman J, "Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden : a nationwide study", Eur J Epidemiol, 36, pp.287~298 (2021)[DOI]
- Nordström P, "Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine : a retrospective, total population cohort study in Sweden", Lancet, 399, pp.814~823 (2022)[DOI]
- Han SJ, "Adjusting for confounders in outcome studies using the Korea National Health Insurance Claim Database : a review of methods and applications", J Prev Med Public Health, 57, pp.1~7 (2024)[DOI]
- Park H, "Operational definitions of colorectal cancer in the Korean National Health Insurance database", J Prev Med Public Health, 56, pp.312~318 (2023)[DOI]
- Kang CR, "Coronavirus disease exposure and spread from nightclubs, South Korea", Emerg Infect Dis, 26, pp.2499~2501 (2020)[DOI]